Olmesartan medoxomil + Placebo Tablets
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Diabetes Mellitus, Type 2
Conditions
Diabetes Mellitus, Type 2, Cardiovascular Disease, Kidney Disease
Trial Timeline
Oct 1, 2004 → Jul 1, 2009
NCT ID
NCT00185159About Olmesartan medoxomil + Placebo Tablets
Olmesartan medoxomil + Placebo Tablets is a phase 3 stage product being developed by Daiichi Sankyo for Diabetes Mellitus, Type 2. The current trial status is completed. This product is registered under clinical trial identifier NCT00185159. Target conditions include Diabetes Mellitus, Type 2, Cardiovascular Disease, Kidney Disease.
What happened to similar drugs?
20 of 20 similar drugs in Diabetes Mellitus, Type 2 were approved
Approved (20) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00185159 | Phase 3 | Completed |
| NCT00141453 | Phase 3 | Completed |
Competing Products
20 competing products in Diabetes Mellitus, Type 2